3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
19
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Motor Activity
1
Interventions
Exercise
12
Methods
2
Diet
2
Behavior Therapy
2
secukinumab
1
peficitinib
1
lime
1
cytisine
1
Waiting Lists
1
Telemedicine
1
Spirometry
1
Self-Management
1
Resistance Training
1
Professional Autonomy
1
Nutrition Assessment
1
Metformin
1
Memantine
1
High-Intensity Interval Training
1
Hematologic Tests
1
Health
1
Exergaming
1
Diet Therapy
1
Counseling
1
Clinical Trials as Topic
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Motor Activity
×
High-Intensity Interval Training
×
Clear all
NCT04593862
2024-09-19
BRAVE
University of Alberta
Phase 2
Completed
25 enrolled